ISA Pharmaceuticals
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC (NCT04398524) | ISA Pharmaceuticals | 2021-07-01 |
| A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC (NCT03669718) | ISA Pharmaceuticals | 2018-11-30 |
Track ISA Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.